Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1973 1
1974 2
1975 2
1976 1
1977 2
1978 2
1979 4
1980 6
1981 5
1982 1
1983 4
1985 2
1986 1
1987 2
1988 1
1989 3
1990 1
1991 4
1992 5
1993 9
1994 7
1995 12
1996 8
1997 10
1998 7
1999 8
2000 11
2001 8
2002 11
2003 11
2004 10
2005 13
2006 14
2007 16
2008 15
2009 11
2010 10
2011 14
2012 12
2013 9
2014 11
2015 4
2016 10
2017 5
2018 4
2019 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Results by year

Filters applied: . Clear all
Page 1
Cancer drug resistance: an evolving paradigm.
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Holohan C, et al. Among authors: johnston pg. Nat Rev Cancer. 2013 Oct;13(10):714-26. doi: 10.1038/nrc3599. Nat Rev Cancer. 2013. PMID: 24060863 Review.
Antimetabolites.
Chu E, Grem JL, Johnston PG, Politi PM, Chabner BA, Allegra CJ. Chu E, et al. Among authors: johnston pg. Cancer Chemother Biol Response Modif. 1992;13:1-30. Cancer Chemother Biol Response Modif. 1992. PMID: 1389906 Review. No abstract available.
Antimetabolites.
Chu E, Johnston PG, Takimoto CH, Politi PM, Grem JL, Chabner BA, Allegra CJ. Chu E, et al. Among authors: johnston pg. Cancer Chemother Biol Response Modif. 1993;14:1-25. Cancer Chemother Biol Response Modif. 1993. PMID: 8312100 Review. No abstract available.
Antimetabolites.
Chu E, Johnston PG, Grem JL, Takimoto CH, Van Groeningen C, Chabner BA, Allegra CJ. Chu E, et al. Among authors: johnston pg. Cancer Chemother Biol Response Modif. 1994;15:1-31. Cancer Chemother Biol Response Modif. 1994. PMID: 7779582 Review. No abstract available.
Antimetabolites.
Grem JL, Takimoto CH, Multani P, Chu E, Ryan D, Chabner BA, Allegra CJ, Johnston PG. Grem JL, et al. Among authors: johnston pg. Cancer Chemother Biol Response Modif. 1999;18:1-38. Cancer Chemother Biol Response Modif. 1999. PMID: 10800475 Review. No abstract available.
Resistance mechanisms to cancer chemotherapy.
Redmond KM, Wilson TR, Johnston PG, Longley DB. Redmond KM, et al. Among authors: johnston pg. Front Biosci. 2008 May 1;13:5138-54. doi: 10.2741/3070. Front Biosci. 2008. PMID: 18508576 Review.
Reply to L. Casadaban et al.
Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM, Mayer RJ, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL, Bertagnolli MM, Warren RS, Innocenti F. Niedzwiecki D, et al. Among authors: johnston pg. J Clin Oncol. 2017 Apr 20;35(12):1373-1374. doi: 10.1200/JCO.2016.71.2646. Epub 2017 Jan 23. J Clin Oncol. 2017. PMID: 28113023 No abstract available.
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.
Bradley CA, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C, Tabernero J, Khawaja HA, Lawler M, Johnston PG, Van Schaeybroeck S; MErCuRIC consortium. Bradley CA, et al. Among authors: johnston pg. Nat Rev Clin Oncol. 2017 Sep;14(9):562-576. doi: 10.1038/nrclinonc.2017.40. Epub 2017 Apr 4. Nat Rev Clin Oncol. 2017. PMID: 28374784 Review.
297 results